Tuberculosis Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study findings have been reported by I. Abubakar and colleagues
July 13th, 2009
"The emergence of multidrug-resistant tuberculosis (MDRTB) and extensively drug-resistant tuberculosis (XDRTB) is a threat to global tuberculosis control. Limited information is, however, available on the outcome of XDRTB cases," scientists in London, the United Kingdom report. "This study describes the susceptibility to second-and third-line antituberculosis drugs among MDRTB cases and treatment outcome of identified XDRTB cases. The results of second-line antituberculosis drug susceptibility tests in the UK between January 1995 and December 2007 were retrospectively reviewed and clinicians contacted for treatment outcome of XDRTB cases. included all 678 patients with...
Source: Tuberculosis Week (2009-07-13)
|
